Stoke Therapeutics (STOK) Retained Earnings: 2022-2025
Historic Retained Earnings for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to -$439.8 million.
- Stoke Therapeutics' Retained Earnings rose 8.45% to -$439.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$439.8 million, marking a year-over-year increase of 8.45%. This contributed to the annual value of -$490.8 million for FY2024, which is 22.14% down from last year.
- Latest data reveals that Stoke Therapeutics reported Retained Earnings of -$439.8 million as of Q3 2025, which was down 9.55% from -$401.4 million recorded in Q2 2025.
- Over the past 5 years, Stoke Therapeutics' Retained Earnings peaked at -$220.7 million during Q1 2022, and registered a low of -$490.8 million during Q4 2024.
- For the 3-year period, Stoke Therapeutics' Retained Earnings averaged around -$410.8 million, with its median value being -$401.8 million (2023).
- Its Retained Earnings has fluctuated over the past 5 years, first plummeted by 44.83% in 2023, then rose by 11.74% in 2025.
- Quarterly analysis of 4 years shows Stoke Therapeutics' Retained Earnings stood at -$297.1 million in 2022, then crashed by 35.23% to -$401.8 million in 2023, then fell by 22.14% to -$490.8 million in 2024, then rose by 8.45% to -$439.8 million in 2025.
- Its Retained Earnings was -$439.8 million in Q3 2025, compared to -$401.4 million in Q2 2025 and -$378.0 million in Q1 2025.